- Home
- ITOS vs UIS Comparison
ITOS vs UIS Comparison
Compare ITOS & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- UIS
- Stock Information
- Founded
- ITOS 2011
- UIS 1942
- Country
- ITOS United States
- UIS United States
- Employees
- ITOS N/A
- UIS N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- UIS EDP Services
- Sector
- ITOS Health Care
- UIS Technology
- Exchange
- ITOS Nasdaq
- UIS Nasdaq
- Market Cap
- ITOS 270.7M
- UIS 271.5M
- IPO Year
- ITOS 2020
- UIS N/A
- Fundamental
- Price
- ITOS $10.02
- UIS $4.77
- Analyst Decision
- ITOS Hold
- UIS Hold
- Analyst Count
- ITOS 6
- UIS 1
- Target Price
- ITOS $10.60
- UIS $6.50
- AVG Volume (30 Days)
- ITOS 2.6M
- UIS 735.5K
- Earning Date
- ITOS 04-28-2025
- UIS 04-30-2025
- Dividend Yield
- ITOS N/A
- UIS N/A
- EPS Growth
- ITOS N/A
- UIS N/A
- EPS
- ITOS N/A
- UIS N/A
- Revenue
- ITOS $35,000,000.00
- UIS $1,952,700,000.00
- Revenue This Year
- ITOS N/A
- UIS N/A
- Revenue Next Year
- ITOS $31.74
- UIS $3.79
- P/E Ratio
- ITOS N/A
- UIS N/A
- Revenue Growth
- ITOS 177.89
- UIS N/A
- 52 Week Low
- ITOS $4.80
- UIS $3.32
- 52 Week High
- ITOS $18.13
- UIS $8.93
- Technical
- Relative Strength Index (RSI)
- ITOS 73.75
- UIS 49.10
- Support Level
- ITOS $8.30
- UIS $4.75
- Resistance Level
- ITOS $11.35
- UIS $4.98
- Average True Range (ATR)
- ITOS 0.53
- UIS 0.23
- MACD
- ITOS 0.22
- UIS -0.07
- Stochastic Oscillator
- ITOS 71.15
- UIS 7.86
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About UIS Unisys Corporation New
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.